Welcome to our dedicated page for Walgreen Boots news (Ticker: WBA), a resource for investors and traders seeking the latest updates and insights on Walgreen Boots stock.
This page provides a focused view of news and announcements historically associated with Walgreens Boots Alliance, Inc. (formerly Nasdaq: WBA) and its related businesses, including Walgreens and Walgreens Specialty Pharmacy. Company communications highlight Walgreens as a U.S. retail pharmacy brand founded in 1901 that serves nearly 9 million customers and patients each day across approximately 8,500 stores in the U.S. and Puerto Rico, and Walgreens Boots Alliance as a pharmacy-led health and wellbeing enterprise formed through the combination of Walgreens and Alliance Boots.
News related to WBA and Walgreens has covered several key themes. One major area is corporate transactions and capital markets activity. In 2025, a series of announcements detailed the Agreement and Plan of Merger under which Blazing Star Merger Sub, Inc. merged with and into Walgreens Boots Alliance, Inc., resulting in the company becoming a wholly owned subsidiary of Blazing Star Parent, LLC, an affiliate of Sycamore Partners. Related releases described tender offers and consent solicitations for various series of Walgreens Boots Alliance and Walgreen Co. notes, pricing terms, extensions of expiration times and settlement dates, and the final results of these offers.
Another important news category involves the company’s transition from public to private ownership. A Form 8-K filed on August 28, 2025 describes the completion of the merger, the cash consideration and divested asset proceed rights received by shareholders, and the cessation of trading of WBA common stock and certain notes on Nasdaq. A subsequent Form 25 documents the removal of these securities from listing, and a Form 15 filed on September 8, 2025 terminates registration and suspends reporting obligations. Sycamore Partners separately announced the completion of its acquisition of Walgreens Boots Alliance, Inc. and its intention that Walgreens, The Boots Group, Shields Health Solutions, CareCentrix and VillageMD operate as standalone companies under private ownership.
Operational and healthcare-focused news also features prominently. Walgreens Specialty Pharmacy announced an expansion of its limited distribution drug network to 265 products, emphasizing its role in specialty medications for patients with rare, complex and chronic diseases and its independence from pharmacy benefit managers. Walgreens has also issued releases on vaccination services, including nationwide flu shot availability for individuals three years and older, walk-in and scheduled appointments, digital check-in features and incentives for myWalgreens members receiving vaccines.
Investors and observers using this news page can review historical coverage of WBA’s merger process, debt tender offers, governance and shareholder actions, as well as Walgreens’ specialty pharmacy initiatives and vaccination programs. For those tracking the evolution of the company, these articles collectively document WBA’s path from a publicly traded integrated healthcare and retail group to a privately held organization under Sycamore Partners, while also illustrating how Walgreens positions its pharmacies and specialty operations within the broader healthcare landscape.
Walgreens Boots Alliance (Nasdaq: WBA) has significantly increased its investment in VillageMD to establish 600 to 700 Village Medical at Walgreens clinics across more than 30 U.S. markets over the next four years. This initiative builds on previous plans, with WBA completing a $750 million investment as part of a larger $1 billion commitment. The clinics aim to provide accessible, coordinated healthcare, particularly in underserved areas, emphasizing the integration of pharmacists into primary care teams for enhanced patient support.
Walgreens aims to complete COVID-19 vaccine first doses for skilled nursing facilities by January 25. The company is expanding vaccine access to assisted living facilities and other vulnerable groups. Since receiving vaccines in December, Walgreens has efficiently vaccinated populations across 49 states and Puerto Rico, administering to over 35,000 long-term care facilities. Planning is underway for broader vaccine distribution to essential workers and seniors aged 75 and older in over 9,000 stores. Walgreens is committed to health equity, focusing on underserved communities impacted by COVID-19.
AmerisourceBergen (ABC) will acquire Walgreens Boots Alliance's (WBA) Alliance Healthcare for $6.5 billion, comprising $6.275 billion in cash and 2 million shares. This acquisition enhances AmerisourceBergen's global distribution capabilities and allows WBA to focus on its retail pharmacy expansion. The deal is projected to create annual run-rate synergies of at least $150 million by the fourth year. Additionally, the U.S. distribution agreement is extended to 2029, aiming for greater efficiencies. AmerisourceBergen expects a high-teens percentage accretion to adjusted EPS in the first fiscal year after closing.
Walgreens Boots Alliance (Nasdaq: WBA) announced that Co-Chief Operating Officer Alex Gourlay and CFO James Kehoe will attend the 39th Annual J.P. Morgan Healthcare Conference on January 13 at 11:40 a.m. ET. This virtual event will be streamed live, accessible via the company's investor relations website. With a presence in over 25 countries and more than 21,000 stores, WBA plays a vital role in health care, committed to enhancing community health and sustainability.
Walgreens is enhancing the holiday shopping experience with extended store hours and convenient services. Many stores are open until midnight until Christmas Eve, with regular hours on Christmas Day. Customers can utilize the Pickup service for same-day collection of over 27,000 items in as little as 30 minutes. Walgreens also offers same-day delivery through partnerships with Postmates and DoorDash. With almost 80% of Americans living within five miles of a Walgreens, the company aims to meet last-minute shopping needs effectively.
Walgreens has initiated the administration of Pfizer’s COVID-19 vaccine at long-term care facilities, marking a significant first in its history. This effort is part of the CDC’s Pharmacy Partnership for Long-term Care Program, focusing on delivering vaccines to approximately 800 facilities across 12 states starting the week of December 21. Walgreens aims to serve nearly 3 million residents and staff at 35,000 facilities. The company is collaborating with federal and state entities to expedite vaccine distribution, while also providing essential medical services throughout the pandemic.
Walgreens is poised to administer COVID-19 vaccines following FDA's emergency use authorization for Pfizer's vaccine. With partnerships involving nearly 35,000 long-term care facilities, Walgreens aims to prioritize vulnerable populations, including healthcare workers and facility residents. The company is prepared to leverage its extensive network of over 9,000 stores and collaborate with federal and state governments to facilitate vaccine distribution. Walgreens' mission emphasizes community health, positioning it as a leader in the vaccination effort against COVID-19.
Walgreens has launched its Flu Index® for the 2020-2021 season, a tool to track flu activity and promote vaccination during National Influenza Vaccination Week (Dec. 6-12). With a surge in COVID-19 cases, health experts stress the importance of flu shots. The index shows low flu activity overall for November, with Texas communities leading in flu cases. Walgreens' Chief Medical Officer emphasized that flu shots are essential to alleviate healthcare system strain during the pandemic. The Flu Index updates weekly and ranks flu activity in markets across the U.S. and Puerto Rico.
Walgreens Boots Alliance (WBA) announced the retirement of Executive VP and Global Chief Human Resources Officer Kathleen Wilson-Thompson, effective January. Pamela Puryear, Ph.D., will succeed her, bringing extensive experience from Zimmer Biomet and Pfizer. Wilson-Thompson is recognized for her pivotal HR leadership during the pandemic and in promoting racial equity. Puryear aims to enhance WBA's HR strategy focusing on culture and employee experience as the company pursues its digital future.
Walgreens Boots Alliance (Nasdaq: WBA) plans to launch 40 new Village Medical at Walgreens clinics by summer 2021, expanding its primary care services in Houston, El Paso, Austin, Phoenix, and Orlando. This initiative follows the successful launch of five clinics in Houston, which received high satisfaction ratings. The clinics will provide comprehensive primary care integrated with pharmacy services to improve patient health outcomes while being accessible to underserved communities. The partnership aims to establish 500 to 700 clinics across over 30 U.S. markets in five years.